Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs

Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs

Nonalcoholic steatohepatitis (NASH) is the most severe manifestation of nonalcoholic fatty liver disease (NAFLD), a common complication of type 2 diabetes, and may lead to cirrhosis and hepatocellular carcinoma. Oxidative stress and liver cell damage are the major triggers of the severe hepatic infl...

Full description

Bibliographic Details
Main Authors: Eleftheria Galatou, Elena Mourelatou, Sophia Hatziantoniou, Ioannis S. Vizirianakis
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Antioxidants
Subjects:
nonalcoholic steatohepatitis (NASH)
nonalcoholic fatty liver disease (NAFLD)
atherosclerosis
inflammation
oxidative stress
GLP-1 RAs
Online Access:https://www.mdpi.com/2076-3921/11/6/1060

Internet

https://www.mdpi.com/2076-3921/11/6/1060

Similar Items